Abstract P4-22-08: A single-arm phase 2 study to assess clinical activity, efficacy and safety of enzalutamide with trastuzumab in HER2+ AR+ metastatic or locally advanced breast c... by Krop, I, Cortes, J, Miller, K, Huizing, MT, Provencher, L, Gianni, L, Chan, S, Trudeau, M, Steinberg, J, Sugg, J, Liosatos, M, Paton, VE, Peterson, A, Wardley, A

Get full text

Abstract OT3-02-02: ENDEAR: A randomized international phase 3 study comparing the efficacy and safety of enzalutamide in combination with paclitaxel chemotherapy or as monotherapy... by Dent, R, Schmid, P, Cortes, J, Kim, S-B, Andre, F, Abramson, V, Cardoso, F, Colleoni, M, Morris, P, Steinberg, J, Tudor, IC, Uppal, H, Paton, VE, Peterson, A, Traina, TA

Get full text

Abstract P3-07-25: Improved clinical outcomes on enzalutamide observed in patients with PREDICT AR+ triple-negative breast cancer: prognosis or prediction? by Miller, K, Krop, I, Schwartzberg, L, Abramson, V, Garcia-Estevez, L, Eakle, J, Nanda, R, Yardley, D, Ademuyiwa, F, Chan, S, Crown, J, Danso, M, Gelmon, K, Ma, L, Martinez-Janez, N, Gradishar, W, Steinberg, J, Tudor, IC, Uppal, H, Paton, VE, Parker, J, Hudis, CA, Traina, TA

Get full text

OT3-01-11: A Randomized, Phase II Multicenter, Double-Blind, Placebo-Controlled Trial Evaluating MetMAb and/or Bevacizumab in Combination with Weekly Paclitaxel in Patients with Me... by Daniel, BR, Campone, M, Dieras, V, Ervin, T, Yu, W, Paton, VE, Xia, Q, Peterson, A

Get full text